RTTNews BiotechDoubao · 实盘不做把握 3/10不做原因:已被定价
北京时间·🕒 发布 02:17:15·⟳ 抓取 02:30:20 +13m05s·⚡ 决策 09-15 02:32:19 +1m59s·42.6 天前
四只生物科技股盘中异动：Tyra增发融资、Nasus IND获批、Bionano研究发表、Tenaya获RMAT认定
这是一篇盘中二次汇总，并非单一公司一手公告；四只股票在成稿时均已大幅上涨，且催化阶段、商业化距离和摊薄性质差异很大。当前时点追入缺少未被定价的edge，未形成可执行的一致多头决策。
📄 原文RTTNews Biotech↗ 原文
Biotech Stocks On The Move: Tyra, Nasus, Bionano & Tenaya Make Gains
Business Business Latest Headlines Top Stories Breaking News Earnings Biotech Investors Stock Alerts IPOs M&A Canadian…
不做 Tyra Biosciences（TYRA.US）
盘中二次报道时已涨15.18%，且4亿美元股票及权证增发带摊薄，催化净方向混合，不追涨。
不做 Nasus Pharma（NSRX.US）
IND clearance为正面但早期，关键研究2026年四季度才启动、数据预计2027年一季度；报道时已涨10.14%，当前缺少未定价edge。
不做 Bionano Genomics（BNGO.US）
同行评议研究不等于订单或收入，商业化传导较远；报道时已涨9.83%，风险回报不足。
不做 Tenaya Therapeutics（TNYA.US）
RMAT认定是监管沟通优势而非获批，关键研究计划尚待更新；低价股盘中已涨8.61%，不做事件追涨。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
四条生物科技正面消息已在盘中分别推动TYRA、NSRX、BNGO和TNYA上涨约9%–15%，报道本身是价格反应后的聚合扩散。Tyra还伴随大额股权融资摊薄，其余多为IND、RMAT或论文等早期研发节点，故不追涨。
🔎 新鲜度:最早出现 2026-09-14 · 扩散 medium · price-in 风险 high ↗
关键理由
- 最新可验证价格显示四只股票均已在盘中完成明显同向重定价，报道发布时涨幅约8.6%–15.2%。
- NSRX的IND放行与TNYA的RMAT是研发监管进展，但尚处关键研究前或关键研究设计阶段，不能直接等同于商业化收入；BNGO为研究发表，TYRA则含融资摊薄。
主要风险
- FOMC利率决议在次日公布，可能放大未盈利生物科技股的盘中波动并削弱事件特异性收益。
- 若公司原始新闻稿早于RTTNews且股价开盘前已有反应，当前涨幅可能主要由消息驱动并接近短线兑现。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-09-14 · 影响 weakens
报道本身显示融资工具为普通股和预融资权证、发行907.9万股，存在明确摊薄；该因素削弱把融资上涨简单视为纯利好。
检索:Tyra Biosciences $400 million offering warrants dilution September 14 2026 原文 ↗
先例如何影响了这次决策
对本次决策的影响:因先例不足且报道时价格已明显反应，最终不给出追涨ENTER。
方向:未构建可量化先例；当前事件包含四种不同阶段催化，不能用泛化生物科技日内涨幅统一校准。
涨幅量级:缺乏同公司、同监管阶段、同盘中相位且锚定一手公告的干净样本，不能据此设定止盈止损。
形态:本条来源本身已显示盘中大幅高开/冲高后的扩散，短线追入存在sell-the-news风险，但没有足够先例量化概率。
原文全文
展开原文 · 10,100 字
Biotech Stocks On The Move: Tyra, Nasus, Bionano & Tenaya Make Gains
Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Biotech Daily Dose
Biotech Stocks On The Move: Tyra, Nasus, Bionano & Tenaya Make Gains
By
RTTNews Staff Writer
✉
Published:
9/14/2026 2:17 PM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Several biotech stocks were in focus Monday, including Tyra Biosciences following a $400 million stock and warrant offering to advance its dabogratinib 3x3 strategy; Nasus Pharma after FDA clearance of its IND for intranasal epinephrine NS002; Bionano Genomics following peer-reviewed OGM study results; and Tenaya Therapeutics after TN-401 received FDA RMAT designation.
Read on…
Tyra Biosciences
(
TYRA
) shares are surging more than 15% after the company announced the pricing of a $400 million underwritten offering of common stock and pre-funded warrants to advance its "dabogratinib 3x3" development strategy in low-grade upper tract urothelial carcinoma, intermediate-risk non-muscle invasive bladder cancer and achondroplasia. The offering includes 9.079 million shares at $22.03 per share, with proceeds expected to support clinical development, preclinical programs, drug discovery and general corporate purposes.
Currently, TYRA is trading at $25.38, up 15.18%.
Nasus Pharma
(
NSRX
) shares are in focus Monday after the company announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for NS002, an investigational intranasal epinephrine powder for the treatment of anaphylaxis. Nasus plans to initiate a pivotal study in the fourth quarter of 2026, comparing self-administration of NS002 with administration by a healthcare professional as a needle-free alternative to EpiPen. Topline data is expected in the first quarter of 2027. In a recent Phase 2 study, NS002 achieved the critical 100 pg/mL plasma epinephrine threshold, with a median T100 of 1.69 minutes versus 3.47 minutes for EpiPen.
Currently, NSRX is trading at $3.75, up 10.14%.
Shares of
Bionano Genomics
(
BNGO
) are surging more than 9% after the company announced that three independently authored, peer-reviewed studies demonstrated that optical genome mapping can uncover clinically significant structural genomic alterations missed by conventional cytogenetic methods. OGM identified high-risk genomic abnormalities across MDS, AML and therapy-related myeloid neoplasms, including chromoanagenesis and other structural variants linked to poorer survival. Across all three studies, OGM was interpretable in 100% of samples.
Currently, BNGO is trading at $1.33, up 9.83%.
Tenaya Therapeutics
(
TNYA
) announced that the U.S. FDA granted RMAT designation to TN-401 for PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC). The designation was supported by interim RIDGE-1 data showing reductions in premature ventricular contractions and non-sustained ventricular tachycardias following a single infusion. Tenaya expects additional trial data and an update on plans for a pivotal study in the fourth quarter of 2026.
Currently, TNYA is trading at $0.62, up 8.61%.
Did you know?
September is Blood Cancer Awareness Month, highlighting blood cancers such as leukemia, lymphoma and myeloma and raising awareness of the importance of early diagnosis, treatment and research.
For comments and feedback contact: editorial@rttnews.com
Business News
Slide Shows
Biotech Stocks Facing FDA Decision In September 2026
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Latest Updates on Middle East War
U.S. Stocks Pulling Back Sharply As Crude Oil Prices Rebound
September 14, 2026 11:00 ET
U.S. Dollar Ticks Higher Amid Inflation Data Release, Expectations Of Reopening Of Strait Of Hormuz
September 11, 2026 17:00 ET
Crude Oil Slumps Amid Rising Expectations Of An End To Hormuz Crisis, Profit-taking
September 11, 2026 14:41 ET
U.S. Dollar Advances Amid Oil-Linked Inflation Concerns, PPI Data Release
September 10, 2026 17:00 ET
Futures Pointing To Initial Pullback On Wall Street
September 14, 2026 08:55 ET
View More
Global Economics Weekly Update - Sep 07 – Sep 11, 2026
September 11, 2026 16:26 ET
Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.
View More Videos
RELATED NEWS
Tyra Prices $400 Mln Underwritten Offering Of Stock & Warrants To Advance Dabogratinib 3x3
Tyra Biosciences Stock Plunges 22% Despite Positive Bladder Cancer Data
Tyra Biosciences Reports Positive SURF302 Results; Plans Phase 3 In LG IR NMIBC
Tyra Biosciences (TYRA): Can Dabogratinib Redefine FGFR3-Driven Bladder Cancer?
Latest Updates on COVID-19
COVID-19 Sees Late-Summer Rise Across 49 US States
September 03, 2026 12:52 ET
COVID-19 Infections Rising In All 50 US States, CDC Data Shows
August 20, 2026 14:09 ET
COVID-19 Pandemic Linked To Higher Loneliness And Isolation In England, Study Finds
August 19, 2026 14:02 ET
View More
Editor's Pick
Most Read
Most Emailed
Microsoft AI Releases Draft Code Of Conduct For MAI Models
September 14, 2026 10:41 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Google To Invest 13 Bln Euros In Finland To Develop AI Infra, Clean Energy
September 09, 2026 09:11 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Orion180 Plans Up To $340 Mln IPO
September 09, 2026 08:04 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
HP Partners With Red Hat For AI Workloads; Shares Up
September 09, 2026 15:46 ET
Apple Unveils New AirPods And Apple Watch Lineup With Enhanced Audio, Health And AI Features
September 09, 2026 16:47 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Blackstone To Buy Flow Control Holdings From Audax For Undisclosed Terms
September 10, 2026 11:20 ET
Atlantic HPC Group To Go Public Via Aperture AC Merger
September 11, 2026 08:16 ET
Google Wallet Rolls Out Full-Screen Redesign For Passes On Android
September 11, 2026 17:41 ET
SEALSQ H1 Loss Widens From Higher Expenses; Reaffirms FY26 Outlook
September 11, 2026 13:24 ET
Ageas Completes Sale Of 30.95% Maybank Ageas Stake To Maybank For EUR 1.1 Bln
September 11, 2026 01:43 ET
Holcim Invests In Cloud Cycle
September 09, 2026 03:16 ET
E79 Gold Mines Limited Full Year Sales Increase
September 09, 2026 01:00 ET
ASE Technology August Revenues Rise 34.6% Y-o-Y
September 09, 2026 03:18 ET
Everpure To Join S&P 500
September 09, 2026 01:09 ET
Victrex Plc Raises FY26 Underlying PBT View; Appoints Interim CFO; Stock Rises 12.8%
September 09, 2026 03:28 ET
Scientex Berhad Q4 Income Climbs
September 09, 2026 01:12 ET
Autohellas S.A. Reveals Fall In H1 Profit
September 09, 2026 03:33 ET
Chime To Acquire Stride Bank
September 09, 2026 01:26 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
Antin Infrastructure Partners SAS Profit Drops In H1
September 09, 2026 01:29 ET
TENPOS HOLDINGS Co Ltd. Reveals Retreat In Q1 Profit
September 09, 2026 05:03 ET
Vallourec, Aramco Ink Agreement For Supply Of Oil Country Tubular Goods
September 09, 2026 01:45 ET
Editors Pick
Microsoft AI Releases Draft Code Of Conduct For MAI Models
September 14, 2026 10:41 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Loading...
Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Biotech Daily Dose
Biotech Stocks On The Move: Tyra, Nasus, Bionano & Tenaya Make Gains
By
RTTNews Staff Writer
✉
Published:
9/14/2026 2:17 PM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Several biotech stocks were in focus Monday, including Tyra Biosciences following a $400 million stock and warrant offering to advance its dabogratinib 3x3 strategy; Nasus Pharma after FDA clearance of its IND for intranasal epinephrine NS002; Bionano Genomics following peer-reviewed OGM study results; and Tenaya Therapeutics after TN-401 received FDA RMAT designation.
Read on…
Tyra Biosciences
(
TYRA
) shares are surging more than 15% after the company announced the pricing of a $400 million underwritten offering of common stock and pre-funded warrants to advance its "dabogratinib 3x3" development strategy in low-grade upper tract urothelial carcinoma, intermediate-risk non-muscle invasive bladder cancer and achondroplasia. The offering includes 9.079 million shares at $22.03 per share, with proceeds expected to support clinical development, preclinical programs, drug discovery and general corporate purposes.
Currently, TYRA is trading at $25.38, up 15.18%.
Nasus Pharma
(
NSRX
) shares are in focus Monday after the company announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for NS002, an investigational intranasal epinephrine powder for the treatment of anaphylaxis. Nasus plans to initiate a pivotal study in the fourth quarter of 2026, comparing self-administration of NS002 with administration by a healthcare professional as a needle-free alternative to EpiPen. Topline data is expected in the first quarter of 2027. In a recent Phase 2 study, NS002 achieved the critical 100 pg/mL plasma epinephrine threshold, with a median T100 of 1.69 minutes versus 3.47 minutes for EpiPen.
Currently, NSRX is trading at $3.75, up 10.14%.
Shares of
Bionano Genomics
(
BNGO
) are surging more than 9% after the company announced that three independently authored, peer-reviewed studies demonstrated that optical genome mapping can uncover clinically significant structural genomic alterations missed by conventional cytogenetic methods. OGM identified high-risk genomic abnormalities across MDS, AML and therapy-related myeloid neoplasms, including chromoanagenesis and other structural variants linked to poorer survival. Across all three studies, OGM was interpretable in 100% of samples.
Currently, BNGO is trading at $1.33, up 9.83%.
Tenaya Therapeutics
(
TNYA
) announced that the U.S. FDA granted RMAT designation to TN-401 for PKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC). The designation was supported by interim RIDGE-1 data showing reductions in premature ventricular contractions and non-sustained ventricular tachycardias following a single infusion. Tenaya expects additional trial data and an update on plans for a pivotal study in the fourth quarter of 2026.
Currently, TNYA is trading at $0.62, up 8.61%.
Did you know?
September is Blood Cancer Awareness Month, highlighting blood cancers such as leukemia, lymphoma and myeloma and raising awareness of the importance of early diagnosis, treatment and research.
For comments and feedback contact: editorial@rttnews.com
Business News
Slide Shows
Biotech Stocks Facing FDA Decision In September 2026
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Latest Updates on Middle East War
U.S. Stocks Pulling Back Sharply As Crude Oil Prices Rebound
September 14, 2026 11:00 ET
U.S. Dollar Ticks Higher Amid Inflation Data Release, Expectations Of Reopening Of Strait Of Hormuz
September 11, 2026 17:00 ET
Crude Oil Slumps Amid Rising Expectations Of An End To Hormuz Crisis, Profit-taking
September 11, 2026 14:41 ET
U.S. Dollar Advances Amid Oil-Linked Inflation Concerns, PPI Data Release
September 10, 2026 17:00 ET
Futures Pointing To Initial Pullback On Wall Street
September 14, 2026 08:55 ET
View More
Global Economics Weekly Update - Sep 07 – Sep 11, 2026
September 11, 2026 16:26 ET
Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.
View More Videos
RELATED NEWS
Tyra Prices $400 Mln Underwritten Offering Of Stock & Warrants To Advance Dabogratinib 3x3
Tyra Biosciences Stock Plunges 22% Despite Positive Bladder Cancer Data
Tyra Biosciences Reports Positive SURF302 Results; Plans Phase 3 In LG IR NMIBC
Tyra Biosciences (TYRA): Can Dabogratinib Redefine FGFR3-Driven Bladder Cancer?
Latest Updates on COVID-19
COVID-19 Sees Late-Summer Rise Across 49 US States
September 03, 2026 12:52 ET
COVID-19 Infections Rising In All 50 US States, CDC Data Shows
August 20, 2026 14:09 ET
COVID-19 Pandemic Linked To Higher Loneliness And Isolation In England, Study Finds
August 19, 2026 14:02 ET
View More
Editor's Pick
Most Read
Most Emailed
Microsoft AI Releases Draft Code Of Conduct For MAI Models
September 14, 2026 10:41 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Google To Invest 13 Bln Euros In Finland To Develop AI Infra, Clean Energy
September 09, 2026 09:11 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Orion180 Plans Up To $340 Mln IPO
September 09, 2026 08:04 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
HP Partners With Red Hat For AI Workloads; Shares Up
September 09, 2026 15:46 ET
Apple Unveils New AirPods And Apple Watch Lineup With Enhanced Audio, Health And AI Features
September 09, 2026 16:47 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Blackstone To Buy Flow Control Holdings From Audax For Undisclosed Terms
September 10, 2026 11:20 ET
Atlantic HPC Group To Go Public Via Aperture AC Merger
September 11, 2026 08:16 ET
Google Wallet Rolls Out Full-Screen Redesign For Passes On Android
September 11, 2026 17:41 ET
SEALSQ H1 Loss Widens From Higher Expenses; Reaffirms FY26 Outlook
September 11, 2026 13:24 ET
Ageas Completes Sale Of 30.95% Maybank Ageas Stake To Maybank For EUR 1.1 Bln
September 11, 2026 01:43 ET
Holcim Invests In Cloud Cycle
September 09, 2026 03:16 ET
E79 Gold Mines Limited Full Year Sales Increase
September 09, 2026 01:00 ET
ASE Technology August Revenues Rise 34.6% Y-o-Y
September 09, 2026 03:18 ET
Everpure To Join S&P 500
September 09, 2026 01:09 ET
Victrex Plc Raises FY26 Underlying PBT View; Appoints Interim CFO; Stock Rises 12.8%
September 09, 2026 03:28 ET
Scientex Berhad Q4 Income Climbs
September 09, 2026 01:12 ET
Autohellas S.A. Reveals Fall In H1 Profit
September 09, 2026 03:33 ET
Chime To Acquire Stride Bank
September 09, 2026 01:26 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
Antin Infrastructure Partners SAS Profit Drops In H1
September 09, 2026 01:29 ET
TENPOS HOLDINGS Co Ltd. Reveals Retreat In Q1 Profit
September 09, 2026 05:03 ET
Vallourec, Aramco Ink Agreement For Supply Of Oil Country Tubular Goods
September 09, 2026 01:45 ET
Editors Pick
Microsoft AI Releases Draft Code Of Conduct For MAI Models
September 14, 2026 10:41 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Loading...
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。